Age is the main factor affecting fertility in women, as egg quality declines with aging, especially after 35 years, according to the World Health Organization. This fertility reduction is associated with a lower quantity and reduced quality of eggs. Additionally, the risk of miscarriage also increases with age, being more likely after 40.
According to the Society for Assisted Reproductive Technology, only 10% of patients between 41 and 42 achieve a viable embryo, so ovarian restoration is recommended before fertilization. This is where the innovative approach of MORE® comes in, incorporating advanced techniques to improve egg quality and embryo development, setting a precedent in the field of assisted reproduction.
Before MORE®, options were limited for these patients, often resorting to egg donation. MORE® offers an alternative for ovarian restoration, providing a better chance for eggs to divide correctly and result in a viable embryo.